Good day, everyone and welcome to Pfizer’s Analyst and Investor Call to Review Oncology Business and ASCO Data Presentations. Today’s call is being recorded. At this time, I would like to turn the ...
Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of fundamentals to assess what this could mean for future share prices, as stock ...
Pfizer stock (NYSE: PFE) lost about 5% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli Lilly ...
Ideaya Biosciences (IDYA) announced the first reported median overall survival results from their Phase 1/2 clinical trial evaluating darovasertib, the company’s investigational oral protein kinase C ...
Pfizer is still trading at a price we saw back in 2000. For once, it shows several drugs in its pipeline. Can you forgive a stock that failed you? Is it time to forget? Forget that Pfizer (NYSE:PFE), ...
Pfizer Inc. (NYSE:PFE) is included among the 12 Best Dividend Paying Stocks to Buy Now. Pfizer Inc. (NYSE:PFE) ranks among the world’s top pharmaceutical companies, with vast resources to back its ...
Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback